Latest / Dayton News Today | 2 Min News | The Daily News Now!
FDA Approves Breakthrough Pancreatic Cancer Pill | Dayton News
FDA just approved a groundbreaking new pill for advanced pancreatic cancer—daraxonrasib, designed for patients who’ve already tried chemo. It blocks a protein found in 90% of cases that fuels tumor growth, offering a lifeline where few existed before. Early results show patients living over 13 months on average—compared to under 7 with standard treatment—and some even surviving years. Doctors call it life-altering, shifting the grim narrative around this deadly disease. Side effects include skin rashes and stomach issues, and the monthly cost hits $39,800—but insurance will likely cover most…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.